Butylene Glycol, Hydrogenated Coconut Oil, Butyrospermum Parkii (Shea) Butter, Palmitoyl Tripeptide-1, Palmitoyl Tetrapeptide-7

CHEBI:CHEBI_755231

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

active_ingredient_name
BUTYLENE GLYCOL
listing_expiration_date
20241231
dosage_form
CREAM
route
TOPICAL
marketing_category
UNAPPROVED DRUG OTHER
product_type
HUMAN OTC DRUG
active_ingredient_strength
.000006 g/100mL
marketing_start_date
20170101
package_marketing_start_date
20170101
unii
JY81OXM1OM
labeler_name
BUDDATE Co Ltd
manufacturer_name
BUDDATE Co Ltd
generic_name
Butylene Glycol, Hydrogenated Coconut Oil, Butyrospermum Parkii (Shea) Butter, Palmitoyl Tripeptide-1, Palmitoyl Tetrapeptide-7
brand_name
BUDDATE REGES INTENSIVE TREATMENT
brand_name_base
BUDDATE REGES INTENSIVE TREATMENT
product_ndc
71173-3000
spl_id
8223be93-b9a1-01ba-e053-2991aa0acc25
package_ndc
71173-3000-1
package_description
70 mL in 1 TUBE (71173-3000-1)
spl_set_id
46495321-fb14-3479-e054-00144ff88e88
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class